SM(d18:1/18:0)
|
Basic information |
| Metabolite name | SM(d18:1/18:0) |
 | HMDB0001348 |
 |
C00550 |
 |
6453725 |
| Synonyms | sphingomyelin (d18:1/20:0, d16:1/22:0); |
| No. of studies | 9 |
|
Basic information |
| Metabolite name | SM(d18:1/18:0) |
| HMDB0001348 |
|
C00550 |
|
6453725 |
| Synonyms | sphingomyelin (d18:1/20:0, d16:1/22:0); |
| No. of studies | 9 |
|
Relationship between SM(d18:1/18:0) and depression (count: 9) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M101 | Type1 | CSD group vs. control group | Faece | C57BL/6 mouse | Up |
| Study M1041 | Type2 | pilocarpine + mitochondrial transplantation group vs. pilocarpine group | Hippocampus | C57BL/6J mouse | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Down |
| Study M507 | Type3 | amitriptyline-treated group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M648 | Type1 | ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, discovery cohort | Plasma | Human | Down |
| Study M687 | Type2 | Kai-Xin-San group vs. depression group | Serum | Human | Up |
| Study M749 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Faece | BALB/c mouse | Down |